Assignee
TULEX PHARMACEUTICALS INC
US·8 granted patents·6 pending applications·11 citations·filing 2019–2025
Top patents by PatentIndex Score
14 records- 0195US11433046B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2021·Granted Sep 6, 2022·3 cites·17 claims
- 0294US11911362B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2023·Granted Feb 27, 2024·1 cites·20 claims
- 0393US12343372B2Desmopressin oral compositionsTULEX PHARMACEUTICALS INC·Filed 2024·Granted Jul 1, 2025·2 cites·29 claims
- 0493US12214010B2Desmopressin oral compositionsTULEX PHARMACEUTICALS INC·Filed 2024·Granted Feb 4, 2025·2 cites·22 claims
- 0593US11826343B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2023·Granted Nov 28, 2023·1 cites·19 claims
- 0693US11633374B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2022·Granted Apr 25, 2023·2 cites·20 claims
- 0788US12290503B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2024·Granted May 6, 2025·0 cites·19 claims
- 0881US12576125B2Desmopressin oral compositionsTULEX PHARMACEUTICALS INC·Filed 2025·Granted Mar 17, 2026·0 cites·20 claims
- 0980US2025275941A1Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1073US2021169844A1Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1165US2025144106A1Ready to use non-aqueous solutions of lamotrigineTULEX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1261US2025134883A1Novel compositionsTULEX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1358US2024299307A1Extended-release compositions comprising atomoxetineTULEX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1444US2022265566A1Atovaquone nanoparticulate compositionsTULEX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TULEX PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →